Lupron for Precocious Puberty and Beyond: Two Decades of Regulatory Silence

Recent attention in a dual Reveal and Kaiser Health News Report (‘Kaiser Report’) to the risks of Lupron’s use in children with central precocious puberty (PP) or growth issues, and to Lupron’s risks in general, presents an opportunity to continue the disclosures on the risks of Lupron. This is the second part in a 6-week series exploring¬† numerous issues associated with the use of Lupron in the pediatric and teen populations. The series began last week with the voices of the mothers of harmed children and the now-adult suffering children. FDA Inaction on Lupron Safety Issues: What They Knew WhenLike … Continue reading Lupron for Precocious Puberty and Beyond: Two Decades of Regulatory Silence